James Bradley Breitmeyer, M.D., Ph.D.

Began fellowship in 1983

Address Harvard Clinical Research Institute
900 Commonwealth Avenue
Second Floor
Boston, MA 02215
Telephone 617-632-1400
E-mail james_breitmeyer@hms.harvard.edu
Web site URL http://hcri@hms.harvadr.edu
Board certification Oncology
Principal employment Academic
Current position President and CEO, Associate Professor
Academic affiliation Department of Medicine
Harvard Medical School, Mass General, Brigham and Women's
Boston, MA
Professional activities Jim Breitmeyer is the President and CEO of the Harvard Clinical Research Institute (HCRI), the newly formed joint venture between Harvard Medical School, CareGroup Healthcare System (including Beth Israel Deaconess Medical Center), and Partners Healthcare System (including Massachusetts General Hospital and the Brigham and Women's Hospital). HCRI was established to expand and enhance clinical research activities in the Harvard medical community, promote inter-institutional collaboration in clinical research at Harvard, and provide leadership in national and international clinical trials initiatives. HCRI will facilitate interactions between Harvard faculty members and developers of pharmaceuticals, biologics, and clinical devices. Breitmeyer received the Ph.D. degree in immunology and the M.D. degree from Washington University in St. Louis, and residency and post-doctoral training at Washington University and Harvard Medical School. He is board certified in Internal Medicine and Oncology. After several years of patient care and basic and clinical research at the Dana-Farber Cancer Institute and Harvard Medical School, he became Senior Vice President and Chief Medical Officer of Serono laboratories in Norwell, MA. He was involved in successful drug and biologic applications in the United States, Europe and Japan.
Percent effort 2% Teaching
20% Research
75% Administration
Research support Industry (Clinical trials)